Thursday, July 18, 2024
HomeLaw firmsDeals and TransactionsLuthra and Luthra Advises Kotak PE on its Investment of ₹400 Crore...

Luthra and Luthra Advises Kotak PE on its Investment of ₹400 Crore in Biorad Medisys

Kotak PE Invests ₹400 Crore in Biorad Medisys with Legal Counsel from Luthra and Luthra

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has invested up to ₹400 crore in Biorad Medisys Private Limited, a manufacturer of medical devices. Luthra and Luthra Law Offices India provided legal representation for Kotak in this significant investment.

The legal team from Luthra and Luthra included Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate), and Aashi Shah (Associate).

About Kotak PE: Kotak Private Equity, through its various funds like Kotak Strategic Situations India Fund II, focuses on making strategic investments in high-growth potential sectors. Managed by Kotak Alternate Asset Managers Limited, it leverages its expertise to support and enhance the value of its portfolio companies.

About Biorad Medisys: Biorad Medisys Private Limited is a prominent manufacturer of medical devices, known for its innovative solutions and contributions to the healthcare industry. The investment by Kotak PE is expected to support the company’s growth and expansion plans.

Share your news, articles, deals, columns, or press releases with us! Click the link to submit and join our platform today.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments